<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:podcast="https://podcastindex.org/namespace/1.0" xmlns:media="http://search.yahoo.com/mrss/" version="2.0"><channel><title>Beta Finch - CVS Health - CVS - EN</title><link>https://betafinch.com</link><description><![CDATA[AI-powered earnings call analysis for CVS Health (CVS). Two AI hosts break down quarterly results, key metrics, and market implications in digestible podcast episodes.]]></description><atom:link href="https://www.spreaker.com/show/7457623/episodes/feed" rel="self" type="application/rss+xml"/><language>en</language><category>Investing</category><copyright>2026 Beta Finch</copyright><image><url>https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/e74984fc42490fae972a8c60910eb2b1.jpg</url><title>Beta Finch - CVS Health - CVS - EN</title><link>https://betafinch.com</link></image><lastBuildDate>Fri, 13 Nov 2026 14:32:20 +0000</lastBuildDate><itunes:author>Beta Finch</itunes:author><itunes:owner><itunes:name>Beta Finch</itunes:name><itunes:email>contact@betafinch.com</itunes:email></itunes:owner><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/e74984fc42490fae972a8c60910eb2b1.jpg"/><itunes:subtitle>AI-powered earnings call analysis for CVS Health (CVS). Two AI hosts break down quarterly results, key metrics, and market implications in digestible podcast episodes.</itunes:subtitle><itunes:summary><![CDATA[AI-powered earnings call analysis for CVS Health (CVS). Two AI hosts break down quarterly results, key metrics, and market implications in digestible podcast episodes.]]></itunes:summary><itunes:category text="Business"><itunes:category text="Investing"/></itunes:category><itunes:explicit>false</itunes:explicit><podcast:guid>0caf7354-bda2-5f7d-a41b-beb6c94f4c18</podcast:guid><podcast:txt purpose="ai-content">true</podcast:txt><itunes:type>episodic</itunes:type><item><title>CVS Health Q3 2026 Earnings Analysis</title><link>https://www.spreaker.com/episode/cvs-health-q3-2026-earnings-analysis--76182143</link><description><![CDATA[More earnings analysis: <a href="https://betafinch.com" rel="noopener">https://betafinch.com</a><br />──────────<br />WELCOME TO BETA FINCH – CVS HEALTH (CVS) Q3 2026 EARNINGS BREAKDOWN<br /><br />ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown, where we turn dense earnings calls into conversations you can actually enjoy. I'm Alex.<br /><br />JORDAN: And I'm Jordan. And Alex, this is not a normal earnings call to kick off with.<br /><br />ALEX: Not even close. But before we get into it — quick disclaimer. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.<br /><br />JORDAN: Good, because today's news is a doozy.<br /><br />ALEX: It really is. CVS Health just announced on this Q3 2026 call that it's splitting into two separate, publicly traded companies — and they're targeting completion in the first half of 2028.<br /><br />JORDAN: Let's break down who gets what. The first company keeps the "CVS Health" name and holds onto Aetna insurance, Caremark pharmacy services, specialty pharmacy, and the care-delivery pieces — Oak Street Health and Signify Health.<br /><br />ALEX: So basically the insurance, PBM, and value-based-care engine.<br /><br />JORDAN: Exactly. Then the second company, which will be called "CVS Pharmacy," gets the retail stores, mail-order pharmacy, MinuteClinic, and this AI platform called Health 100.<br /><br />ALEX: Prem Shah, who currently runs retail, is going to be CEO of that new CVS Pharmacy company. David Joyner stays on as Chairman and CEO of the CVS Health side.<br /><br />JORDAN: And importantly — management says this is expected to be tax-free for shareholders under U.S. federal rules, and existing CVS shareholders will end up owning shares in both new companies once it closes.<br /><br />ALEX: CEO David Joyner was very clear this isn't a distress move. He kept hammering the point that they're doing this "from a position of strength."<br /><br />JORDAN: And honestly, the numbers back that up. Let's talk financials, because the quarter itself was strong, split announcement aside. Revenue came in north of $108 billion for the quarter.<br /><br />ALEX: Adjusted operating income was about $4.2 billion, and adjusted EPS was $2.09 — that's up more than 30% year-over-year.<br /><br />JORDAN: Big jump. And because of that momentum, they raised full-year 2026 adjusted EPS guidance to at least $8.20, up from the prior range of $7.90 to $8.10.<br /><br />ALEX: They also bumped full-year cash flow from operations guidance to at least $15.5 billion. CFO Brian Newman pointed out that's over $5.5 billion higher than their original expectation for the year. That's a massive raise.<br /><br />JORDAN: Segment by segment, it's a good story too. Healthcare Benefits — that's the Aetna insurance piece — posted adjusted operating income of $900 million, up almost $600 million from last year, with the medical benefit ratio improving about 150 basis points to 91.3%.<br /><br />ALEX: That's the Medicare Advantage turnaround everyone's been watching. Executive Steven Nelson said Aetna is actually moving into profitable territory in Medicare Advantage in 2026, after a rough couple of years.<br /><br />JORDAN: Health Services — that's Caremark and specialty pharmacy — delivered $2.1 billion in adjusted operating income, up nearly 3%. And Pharmacy and Consumer Wellness, the retail side, had a really strong quarter: over $1.6 billion in operating income, up more than 10%, driven by almost 4% growth in same-store prescription volumes.<br /><br />ALEX: And get this — GLP-1 prescription volume at retail grew 23% in the quarter. That's a real tailwind.<br /><br />JORDAN: Now let's talk balance sheet, because this matters a lot for the breakup story. They hit their target leverage ratio ahead of schedule, and because of that, they're resuming share buybacks in the fourth quarter.<br /><br />ALEX: Which tells you they're not strapped for cash heading into this separation — they actually have room to return capital to shareholders while also funding two standalone companies.<br /><br />JORDAN: Le<br /><br />This episode includes AI-generated content.]]></description><guid isPermaLink="false">CVS-Q3-2026-en</guid><pubDate>Thu, 05 Nov 2026 00:32:57 +0000</pubDate><enclosure url="https://dts.podtrac.com/redirect.mp3/api.spreaker.com/download/episode/76182143/cvs_2026_q3_480745_en.mp3" length="6484268" type="audio/mpeg"/><podcast:transcript url="https://transcription.spreaker.com/starship/7d66f803-1a13-4669-a29e-6f6ac80f1d89/7d66f803-1a13-4669-a29e-6f6ac80f1d89.srt" type="application/x-subrip" language="en"/><podcast:transcript url="https://transcription.spreaker.com/starship/7d66f803-1a13-4669-a29e-6f6ac80f1d89/7d66f803-1a13-4669-a29e-6f6ac80f1d89.txt" type="text/plain" language="en"/><podcast:transcript url="https://transcription.spreaker.com/starship/7d66f803-1a13-4669-a29e-6f6ac80f1d89/7d66f803-1a13-4669-a29e-6f6ac80f1d89.vtt" type="text/vtt" language="en"/><podcast:txt purpose="ai-content">true</podcast:txt><itunes:author>Beta Finch</itunes:author><itunes:subtitle>More earnings analysis: https://betafinch.com
──────────
WELCOME TO BETA FINCH – CVS HEALTH (CVS) Q3 2026 EARNINGS BREAKDOWN

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown, where we turn dense earnings calls into conversations you...</itunes:subtitle><itunes:summary><![CDATA[More earnings analysis: <a href="https://betafinch.com" rel="noopener">https://betafinch.com</a><br />──────────<br />WELCOME TO BETA FINCH – CVS HEALTH (CVS) Q3 2026 EARNINGS BREAKDOWN<br /><br />ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown, where we turn dense earnings calls into conversations you can actually enjoy. I'm Alex.<br /><br />JORDAN: And I'm Jordan. And Alex, this is not a normal earnings call to kick off with.<br /><br />ALEX: Not even close. But before we get into it — quick disclaimer. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.<br /><br />JORDAN: Good, because today's news is a doozy.<br /><br />ALEX: It really is. CVS Health just announced on this Q3 2026 call that it's splitting into two separate, publicly traded companies — and they're targeting completion in the first half of 2028.<br /><br />JORDAN: Let's break down who gets what. The first company keeps the "CVS Health" name and holds onto Aetna insurance, Caremark pharmacy services, specialty pharmacy, and the care-delivery pieces — Oak Street Health and Signify Health.<br /><br />ALEX: So basically the insurance, PBM, and value-based-care engine.<br /><br />JORDAN: Exactly. Then the second company, which will be called "CVS Pharmacy," gets the retail stores, mail-order pharmacy, MinuteClinic, and this AI platform called Health 100.<br /><br />ALEX: Prem Shah, who currently runs retail, is going to be CEO of that new CVS Pharmacy company. David Joyner stays on as Chairman and CEO of the CVS Health side.<br /><br />JORDAN: And importantly — management says this is expected to be tax-free for shareholders under U.S. federal rules, and existing CVS shareholders will end up owning shares in both new companies once it closes.<br /><br />ALEX: CEO David Joyner was very clear this isn't a distress move. He kept hammering the point that they're doing this "from a position of strength."<br /><br />JORDAN: And honestly, the numbers back that up. Let's talk financials, because the quarter itself was strong, split announcement aside. Revenue came in north of $108 billion for the quarter.<br /><br />ALEX: Adjusted operating income was about $4.2 billion, and adjusted EPS was $2.09 — that's up more than 30% year-over-year.<br /><br />JORDAN: Big jump. And because of that momentum, they raised full-year 2026 adjusted EPS guidance to at least $8.20, up from the prior range of $7.90 to $8.10.<br /><br />ALEX: They also bumped full-year cash flow from operations guidance to at least $15.5 billion. CFO Brian Newman pointed out that's over $5.5 billion higher than their original expectation for the year. That's a massive raise.<br /><br />JORDAN: Segment by segment, it's a good story too. Healthcare Benefits — that's the Aetna insurance piece — posted adjusted operating income of $900 million, up almost $600 million from last year, with the medical benefit ratio improving about 150 basis points to 91.3%.<br /><br />ALEX: That's the Medicare Advantage turnaround everyone's been watching. Executive Steven Nelson said Aetna is actually moving into profitable territory in Medicare Advantage in 2026, after a rough couple of years.<br /><br />JORDAN: Health Services — that's Caremark and specialty pharmacy — delivered $2.1 billion in adjusted operating income, up nearly 3%. And Pharmacy and Consumer Wellness, the retail side, had a really strong quarter: over $1.6 billion in operating income, up more than 10%, driven by almost 4% growth in same-store prescription volumes.<br /><br />ALEX: And get this — GLP-1 prescription volume at retail grew 23% in the quarter. That's a real tailwind.<br /><br />JORDAN: Now let's talk balance sheet, because this matters a lot for the breakup story. They hit their target leverage ratio ahead of schedule, and...]]></itunes:summary><itunes:duration>406</itunes:duration><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/e74984fc42490fae972a8c60910eb2b1.jpg"/><itunes:episodeType>full</itunes:episodeType></item><item><title>Coming Soon: CVS Health (CVS) Earnings Analysis</title><link>https://www.spreaker.com/episode/coming-soon-cvs-health-cvs-earnings-analysis--75739744</link><description><![CDATA[Beta Finch's AI-powered earnings call analysis for CVS Health (CVS) is coming soon. Follow the show to get the first full episode as soon as CVS Health reports.<br /><br />This episode includes AI-generated content.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/75739744</guid><pubDate>Tue, 13 Oct 2026 02:03:02 +0000</pubDate><enclosure url="https://dts.podtrac.com/redirect.mp3/api.spreaker.com/download/episode/75739744/coming_soon_en.mp3" length="1933104" type="audio/mpeg"/><podcast:transcript url="https://transcription.spreaker.com/starship/f68530f2-f735-4687-9216-f4270d0fb513/f68530f2-f735-4687-9216-f4270d0fb513.srt" type="application/x-subrip" language="en"/><podcast:transcript url="https://transcription.spreaker.com/starship/f68530f2-f735-4687-9216-f4270d0fb513/f68530f2-f735-4687-9216-f4270d0fb513.txt" type="text/plain" language="en"/><podcast:transcript url="https://transcription.spreaker.com/starship/f68530f2-f735-4687-9216-f4270d0fb513/f68530f2-f735-4687-9216-f4270d0fb513.vtt" type="text/vtt" language="en"/><podcast:txt purpose="ai-content">true</podcast:txt><itunes:author>Beta Finch</itunes:author><itunes:subtitle>Beta Finch's AI-powered earnings call analysis for CVS Health (CVS) is coming soon. Follow the show to get the first full episode as soon as CVS Health reports.</itunes:subtitle><itunes:summary><![CDATA[Beta Finch's AI-powered earnings call analysis for CVS Health (CVS) is coming soon. Follow the show to get the first full episode as soon as CVS Health reports.<br /><br />This episode includes AI-generated content.]]></itunes:summary><itunes:duration>121</itunes:duration><itunes:explicit>false</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/e74984fc42490fae972a8c60910eb2b1.jpg"/><itunes:episodeType>full</itunes:episodeType></item></channel></rss>
